The recently developed green laser (GL; wavelength 543 nm) is thought to measure perfusion derived from a more superficial skin layer than does the standard near-infrared laser (RL; wavelength 780 nm). These lasers were used to investigate the disturbances in the different layers of skin perfusion in ischaemic legs before and after treatment and compared with capillary microscopy. Eighteen patients (20 legs) with different stages of leg ischaemia scheduled for a vascular intervention (11 males, 7 females; median age 73, range: 52–81 years; Fontaine stages II–IV) were investigated by means of capillary microscopy, visualising the nail fold capillary perfusion, and a laser Doppler, equipped with a special dual probe conducting both GL and RL. The probe was attached to the pulp and the dorsum of the big toe to assess skin perfusion at rest and during reactive hyperaemia, while sitting and while supine. Resting and hyperaemic perfusion using GL was low and significantly lower (p < 0.01) than with RL in both areas and positions. Laser Doppler perfusion was higher in the pulp than on the dorsum with both wavelengths (p < 0.05). The hyperaemia response was highest using GL and differed among the three techniques. Postural reduction of capillary and RL flow was reduced, but not with GL. After treatment, skin capillary perfusion improved more clearly than did the laser Doppler perfusion with either wavelength, while postural vasoconstriction improved only when measured with the capillary microscope. The differences found between RL and GL Doppler perfusion, but also between GL and capillary microscopy measurements suggest that the GL does measure the more superficial, but not exclusively the nutritive skin perfusion. Clinically, the use of the green laser in its present form in patients with leg ischaemia offers no advantage over the red laser.

1.
Bollinger A, Fagrell B: Clinical Capillaroscopy. A Guide to Its Use in Clinical Research and Practice. Toronto, Hogrefe and Huber, 1990.
2.
Ubbink DT, Jacobs MJHM, Tangelder GJ, Slaaf DW, Reneman RS: The usefulness of capillary microscopy, transcutaneous oximetry and laser Doppler fluxmetry in the assessment of the severity of lower limb ischaemia. Int J Microcirc Clin Exp 1994;14:34–44.
3.
Fagrell B: Vital capillary microscopy – A clinical method for studying changes of the nutritional skin capillaries in legs with arteriosclerosis obliterans. Scand J Clin Lab Invest Suppl 1973;133:2–50.
4.
Ubbink DT, Jacobs MJHM, Slaaf DW: Can transcutaneous oximetry detect nutritive perfusion disturbances in patients with lower limb ischemia? Microvasc Res 1994;4:315–324.
5.
Fagrell B: Advances in microcirculation network evaluation: An update. Int J Microcirc Clin Exp 1995;15(suppl 1):34–40.
6.
Fabricius M, Akgroen N, Dirnagl U, Lauritzen M: Laminar analysis of cerebral blood flow in cortex of rats by laser-Doppler flowmetry: A pilot study. J Cereb Blood Flow Metab 1997;17:1326–1336.
7.
Anderson RR, Parrish JA: The optics of human skin. J Invest Dermatol 1981;77:13–19.
8.
Hales JR, Roberts RG, Westerman RA, Stephens FR, Fawcett AA: Evidence for skin microvascular compartmentalization by laser-Doppler and photoplethysmographic techniques. Int J Microcirc Clin Exp 1993;12:99–104.
9.
Tulevski II, Ubbink DT, Jacobs MJHM: Red and green laser Doppler compared with capillary microscopy to assess skin microcirculation in the feet of healthy subjects. Microvasc Res 1999;58:83–88.
10.
Cisek PL, Eze AR, Comerota AJ, Kerr R, Brake B, Kelly P: Microcirculatory compensation to progressive atherosclerotic disease. Ann Vasc Surg 1997;11:49–53.
11.
Schmidt C, Adechokan S, Mouhli J: Laser-Doppler flowmetry and arterial diseases of the limbs. Correlations with measurement of transcutaneous oxygen pressure (in French). J Mal Vasc 1996;21:294–298.
12.
Ubbink DT, Jacobs MJHM, Slaaf DW, Tangelder GJ, Reneman RS: Posturally induced microvascular constriction in patients with different stages of leg ischaemia and the effect of local skin heating. Clin Sci 1991;81:43–49.
13.
Kernick DP, Tooke JE, Shore AC: The biological zero signal in laser Doppler fluximetry – origins and practical implications. Pflügers Arch 1999;437(4):624–631.
14.
Ray SA, Buckenham TM, Belli AM, Taylor RS, Dormandy JA: The predictive value of laser Doppler fluxmetry and transcutaneous oximetry for clinical outcome in patients undergoing revascularisation for severe leg ischaemia. Eur J Vasc Endovasc Surg 1997;13:54–59.
15.
Yarborough M: Taking the confusion out of matching medical lasers to applications. Photonics Spectra 1992;26:88–94.
16.
Malanin K, Kolari PJ: The venoarteriolar response of the skin in healthy legs measured at different depths. Clin Physiol 1998;18(5):441–446.
17.
Proano E, Perbeck L: Changes in skin blood flow in ischemic limbs after vascular reconstruction measured by fluorescein flowmetry and laser Doppler flowmetry. Clin Physiol 1993;13:599–609.
18.
Ubbink DT, Kitslaar PJEHM, Tordoir JHM, Tangelder GJ, Reneman RS, Jacobs MJHM: The relevance of posturally induced microvascular constriction after revascularisation in patients with chronic leg ischaemia. Eur J Vasc Surg 1992;6:525–532.
19.
Ubbink DT, Spincemaille GHJJ, Reneman RS, Jacobs MJHM: Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J Vasc Surg 1999;30:114–121.
20.
Vayssairat M, Tribout L, Gouny P, Gaitz JP, Baudot N, Cheynel C, Nussaume O: Importance of cutaneous postural reflex vasoconstriction in patients with atherosclerotic occlusive disease of the lower extremities. Int Angiol 1998;17:53–57.
21.
Walden R, Bass A, Balaciano M, Modan M, Zulty L, Adar R: Laser Doppler flowmetry in lower extremity ischemia: Application and interpretation. Ann Vasc Surg 1992;6:511–516.
22.
Malanin K, Vilkko P, Kolari PJ: Venoarteriolar response to experimental venous hypertension in legs with chronic venous insufficiency and in healthy legs, measured using a double-wavelength laser Doppler technique. Angiology 1998;49(9):729–733.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.